Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoires Bengué was a French pharmaceutical company founded in 1891 by Dr. Jules Bengué. The company is globally recognized for the invention of Baume Bengué, the first topical analgesic balm utilizing menthol and methyl salicylate. This product was later introduced to the United States and became the household brand Bengay. The firm specialized in treatments for rheumatism, gout, and neuralgia, focusing on topical delivery systems. Over the decades, the company's assets were integrated into larger pharmaceutical portfolios, starting with Warner-Lambert and eventually Pfizer. Today, the legacy of Jules Bengué's research is maintained by Kenvue, which continues to market the Bengay product line. The company's work laid the foundation for modern over-the-counter topical pain relief.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jules Bengué.